$ADPT Adaptive Biotechnologies Corp Insider Trading Week 25/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp in week 25/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 400,200 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 411,300 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 422,400 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 47.25 | 3,743 | 176,857 | 679 | 4.4 K to 679 (-84.64 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.84 | 6,657 | 311,814 | 4,422 | 11.1 K to 4.4 K (-60.09 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 45.36 | 700 | 31,752 | 11,079 | 11.8 K to 11.1 K (-5.94 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.38 | 2,823 | 130,931 | 679 | 3.5 K to 679 (-80.61 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 45.72 | 8,277 | 378,424 | 3,502 | 11.8 K to 3.5 K (-70.27 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.95 | 9,600 | 450,720 | 679 | 10.3 K to 679 (-93.39 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 46.21 | 1,500 | 69,315 | 10,279 | 11.8 K to 10.3 K (-12.73 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 37,188 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 1,109 | 8,650 | 39,472 | |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 46.68 | 2,880 | 134,438 | 1,300 | 4.2 K to 1.3 K (-68.90 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 4,180 | 2.4 K to 4.2 K (+73.52 %) |
Jun 25 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 1,109 | 8,650 | 2,409 | 1.3 K to 2.4 K (+85.31 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 33,132 | 10,934 | 348,748 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.15 | 13,503 | 623,163 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.65 | 19,629 | 896,064 | 1,791,683 | 1.8 M to 1.8 M (-1.08 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 33,132 | 10,934 | 1,811,312 | 1.8 M to 1.8 M (+1.86 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 33,132 | 10,934 | 348,748 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 46.15 | 13,503 | 623,163 | 1,778,180 | 1.8 M to 1.8 M (-0.75 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 45.65 | 19,629 | 896,064 | 1,791,683 | 1.8 M to 1.8 M (-1.08 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 33,132 | 10,934 | 1,811,312 | 1.8 M to 1.8 M (+1.86 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 19,000 | 15,960 | 121,000 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 45.38 | 14,694 | 666,814 | 10,000 | 24.7 K to 10 K (-59.50 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 44.66 | 4,306 | 192,306 | 24,694 | 29 K to 24.7 K (-14.85 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 19,000 | 15,960 | 29,000 | 10 K to 29 K (+190.00 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 4,167 | |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 45.00 | 417 | 18,765 | 0 | 417 to 0 (-100.00 %) |
Jun 23 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |